Abstract
Human behavior significantly influences infectious disease transmission, yet traditional models often overlook this factor, limiting predictions of disease and the associated socioeconomic impacts. We introduce a feedback-informed epidemiological model that integrates economic decision-making with infectious disease dynamics. Individuals weigh costs and benefits, then choose behaviors that influence their risk of infection and disease progression, thereby shaping population-level dynamics. Applying this model to a scenario based on the early COVID-19 pandemic, we examine decisions to abstain from work to mitigate infection risk. Our findings reveal that feedback between disease and behavior notably affect infection rates and overall welfare, especially when accounting for individual economic and health vulnerabilities, which are often in tension. We evaluate counterfactual policies, including labor restrictions and cash transfers, illustrating how our framework can simultaneously address epidemiological, economic, and equity-related questions. This flexible and extendable modeling framework offers a powerful tool for assessing infectious disease interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the US National Science Foundation (Award 2229996).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
No data was produced in the present study. Code used to simulate the model is publicly available in on Github.
